IN discussing the fate of anmsthetic drugs I shall be dealing mainly with compounds which are broken down in the body, and I shall not refer to the gases and volatile anisthetics.
FATE OF PROCAINE IN THE BODY
Procaine is probably the most rapidly metabolized drug known, there being in the plasma (and in the liver) a special enzyme called "procaine esterase" (Kisch, Koster and Strauss, 1943) which hydrolyses the substance to its components, p-aminobenzoic acid (PABA) and diethylamino-ethanol (DEAE).
NH2 NH2
COOCH2CH, N ( C2H5 + HsO COOH + HOCH,CH2 N / C2 H, (procaine) (p-aminobenzoic (diethylamino-ethanol acid, PABA) DEAE)
In man it has been shown by Brodie, Papper and Mark (1950b) that 90% of the PABA and 33 % of the DEAE so formed appear in the urine within twenty-four hours. Only small amounts of PABA occur in the free or acetylated forms, most of the PABA being conjugated with glycine to form anminohippuric acid and some combines with glucuronic acid (Tabor-et al., 1951) . The products of Uetabolism of DEAE are not known.
The rate of hydrolysis of procaine by plasma is very high and Brodie et al. (1950b) found that in vitro the enzyme in human plasma completely destroyed 5 mg./litre of procaine in about five minutes. The safety of intravenous procaine infusions depends on this speedy breakdown, since both toxic effects and therapeutic actions (e.g. analgesia or depression of cardiac excitability) are due to the unchanged procaine and not to the products of breakdown. For reduction of excitability of heart muscle about 30 times as much PABA as is formed from an effective dose of procaine has to be given. In vivo, procaine infusions produce only very low plasma concentrations of the unchanged drug. For example, Brodie et al. (1950b) found that after intravenous infusion in man of 2 grammes of procaine during 105 minutes the procaine plasma level never exceeded 0-2 mg./l., while the concentration of PABA rose to 13 mg./l. and that of DEAE to 2-8 mg./l. Burgen and I (1948) have studied the plasma procaine levels in cats immediately following rapid intravenous injections of procaine and also during short infusions of relatively large doses of the drug. In both cases the plasma procaine levels fell rapidly after the drug administration ended. For example, after injection of 30 mg. of procaine in 30 seconds, the plasma level fell from 77 mg./l. to 7.5 mg./l. in five minutes. This fall could be due to:
(1) Dilution, resulting from diffusion of the drug from the blood stream into the tissue fluids of the body.
(2) Fixation of unchanged procaine by the tissues.
(3) Destruction in blood and tissues.
(4) Excretion.
Excretion of unchanged procaine in the urine (about 3 % of the total) was quite inadequate to explain the rapid fall in plasma procaine concentration. Calculations showed, too, that even if the procaine had been uniformly distributed throughout the total body water, this dilution could only account for less than one-third of the procaine which had disappeared from the blood. It was therefore clear that the injected procaine had been extensively fixed by the tissues, or speedily destroyed: the simultaneous increase in plasma PABA concentration in fact showed that the disappearance of procaine from the blood was mainly due to its breakdown: At the end of an infusion of 80 mg. of procaine in thirteen minutes the plasma level fell from 65 mg./l. to 25 mg./l. during the next five minutes. In this case the drug would have been quite uniformly distributed throughout the body fluids during the infusion and the subsequent rapid fall in plasma level must have been almost entirely due to destruction of procaine.
We also tried to determine what part such organs as the kidney and liver play in the destruction of procaine. The kidney certainly eliminates only a minute fraction of injected procaine via the urine, but it might still destroy the substance; however, in experiments in which we tied off the renal pedicles we found no evidence that this was the case. On the other hand, there was good evidence that in eviscerated cats (with no portal blood flow) the liver played a significant part in the destruction of procaine, since occlusion of the hepatic artery during an infusion caused the plasma procaine level to rise sharply. These experiments have been described to illustrate how the fate of a drug may be followed when its detoxication products are known and when sensitive chemical methods are available for determination of the concentrations of the parent compound and its derivatives in the body fluids. However, where one is dealing with such a rapidly destroyed substance it is impossible to determine its concentration in the various organs and tissues of the body. The barbiturates, which are all much more stable than procaine in the body, will be used to illustrate this aspect of distribution.
THE BARBITURATES
Studies on the distribution and fate of the barbiturates have in the past been handicapped by inadequate chemical methods of estimation. The difficulties are discussed in the review by Maynert and Van Dyke (1949) , who point out that most of the methods cannot distinguish between the depressant parent compound and its inactive metabolites. The improved techniques which have recently been developed to overcome this problem have provided more accurate and detailed information which has changed our ideas in some important respects.
Distribution.-In discussing the distribution of the barbiturates it is convenient to deal first with the brain, and it is appropriate to begin by referring to the work of Das (1940) , who studied the speed of onset of action of a number of barbiturates when they were administered intravenously to mice. He found that the median hypnotic doses of thiopentone and hexobarbitone caused sleep in one to two minutes, whereas the corresponding doses of pentobarbitone and barbitone took five and twentytwo minutes respectively. It is interesting to note that Shideman and found that with thiopentone equilibrium between blood and brain was attained one minute after injection. It is also significant that the oil/water coefficient of the rapidly acting thiopentone is-bout 4-7, whereas that of the slow-acting barbitone is 0-214. Using reliable chemical methods of determination Butler (1950) has further shown that the uptake of barbitone by the brain is much slower than that of the rapidly acting Hexethal (Ortal). Butler, in the work just mentioned, and Maynert and Van Dyke (1950) , in experiments on dogs to which they administered barbitone containing 15N, have shown that there is no evidence of selective concentration of barbitone in any particular regions of the brain.
PLASMA LEVELS OF THIOPENTONE AFTER INTRAVENOUS INJECTION
Brodie et al. (1950a) found that after intravenous injection of 04 gramme of thiopentone in two minutes the initial plasma concentration was 28 mg./l. During the first few minutes after injection the plasma level fell rapidly, and subsequently more slowly. After infusions lasting up to fifty minutes the plasma level fell slowly and only about 10-15% of the drug was destroyed per hour. This suggests that the brevity of action of intravenous thiopentone when given as a single dose is due to redistribution rather than detoxication of the drug. After infusions or repeated injections thiopentone is relatively long-acting owing to its rather slow rate of destruction.
Thus the initial high uptake of thiopentone by the brain accounts for the rapid induction of anasthesia, and the subsequent rapid recovery is correlated with the fall in plasma level associated with the speedy redistribution of the drug throughout the body. The sites of redistribution have been studied only recently (Brodie et al., 1950a) . Liver and kidney contain somewhat higher concentrations than occur in plasma, but two to three hours after injection the highest concentrations are found in samples of body fat, in which levels five to ten times those of plasma, may be found. Equilibrium between blood and fat is reached only one to two hours after injection (Shideman and , probably owing to the poor blood supply to this tissue. The implications of this redistribution are important, since the fat constitutes a sort of reservoir in which the thiopentone will be stored and subsequently released to be detoxicated relatively slowly by oxidation. The fat thus behaves as a buffering mechanism which will influence slightly the intensity, and much more the duration of action of thiopentone. The more fat there is in the body the more efficient should this buffering action be, and the briefer should be the effect of a single intravenous injection of thiopentone. It is therefore very important to take into account the variations in fat content of the body which have been reported by McCance and Widdowson (1951) . They estimated the percentage of fat in normal men to be 7-2 to 22.4% of the body-weight and in normal women 12-6 to 28-5% of the body-weight. It would be most interesting to correlate the percentage body fat with duration and intensity of action of thiopentone.
METABOLISM OF BARBITURATES
The metabolic changes undergone by the barbiturates have been reviewed recently by Maynert and Van Dyke (1949) . After allowance has been made for the inadequate methods of determination which have been used in the past the following statements may be made concerning a few of the most important members of this group. Barbitone is excreted unchanged, up to 90% of the administered drug appearing in the urine. Phenobarbitone is excreted unchanged in the urine to about 25 % of the amount given, the remainder being detoxicated, perhaps partly in the kidney. With both these longacting drugs the excretion is slow, lasting several days. The barbiturates which act rapidly and briefly, e.g. pentobarbitone, hexobarbitone and thiopentone, are almost completely destroyed in the body, only traces of unchanged drug appearing in the urine. There is little evidence that significant breakdown of the barbiturate ring occurs, and the suggestion that the sulphur atom of this thiobarbiturate is replaced by oxygen is not supported by studies made with thiopentone containing 35S.
The most important metabolic change undergone by the three short-acting compounds mentioned above is oxidation of the side-chain. Thus pentobarbitone is converted to 5-ethyl: 5(3-hydroxy-1 methylbutyl) barbituric acid. The longer side-chains are much more easily oxidized than the shorter ones. The cyclo-hexenyl ring of hexobarbitone is also oxidized (Bush and Butler, 1941) , and thiopentone is converted to a carboxylic acid (COOH) derivative. All these products of oxidation lack the central nervous depressant actions of the parent compounds.
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SITES OF METABOLISM OF BARBITURATES
The extensive earlier work on the part played by the liver in the breakdown of the barbiturates will not be reviewed here. It may now be said that recent work by Walker and Wynn Parry (1949), Shideman et al. (1947) , and Shideman and has shown that all the shorter-acting barbiturates are detoxicated in the liver. In vitro liver slices, and even cell-free preparations of liver tissue inactivate these barbiturates .
Detoxication may perhaps occur also in other tissues, such as the kidney and brain, but there is little precise information on this point. DISTRIBUTION AND FATE OF d-TUBOCURAIuNE d-Tubocurarine is a quaternary ammonium compound with negligible lipoid solubility. It is therefore to be expected that it will not easily penetrate the cells of the body. Indeed Mahfouz (1949) found that in man the drug was distributed in a volume of fluid equal to that of the plasma volume, the maximum concentration being about 4 sg./ml. at the time of full paralysis. No tubocurarine was found in the red blood cells. Buller and Young (1949) have shown that tubocurarine does not cross the placenta in rabbits, a result which agrees with the clinical finding that the drug may be given for CQsarean section without the danger of paralysing the new-born child. It also seems likely that with the usual doses of tubocurarine little or no penetration into the central nervous tissue occurs, though Salama and Wright (1950) have shown that injections of the drug into the cerebrospinal fluid causes powerful stimulant effects, including convulsions.
In mice, Mahfouz found that 60% of tubocurarine was inactivated in the body within four hours, perhaps largely in striated muscle. There is no evidence that liver or kidney are significant sites of destruction, and hepatic or renal damage does not contra-indicate the administration of tubocurarine.
METHONIUM COMPOUNDS
The methonium compounds such as decamethonium (CIO) and hexamethonium (C6) are quaternary ammonium substances with very low lipoid solubility. One would therefore expect them to be distributed in the plasma and interstitial fluid, without entering the cells of the body. Like tubocurarine they will, of course, become attached to the surface of cells on which they act, e.g. the motor endplates in the case of decamethonium and the ganglion cells of the autonomic nervous system in the case of hexamethonium. Also like tubocurarine, decamethonium does not cross the placental barrier (Young, 1949) .
Methonium compounds are not metabolized in the body and after injection they are almost entirely excreted in the urine (Zaimis, 1950; Milne and Oleesky, 1951) . The drugs pass out via the glomeruli and are neither excreted nor reabsorbed by the cells of the renal tubules. It is therefore important to realize that if the arterial blood pressure is reduced to less than 50 mm.Hg (when glomerular filtration ceases), a drug such as hexamethonium will no longer be excreted even though renal blood flow is well maintained as the result of the vasodilatation induced by the drug.
